San Francisco Sentry Investment Group’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$6K Sell
423
-678
-62% -$9.81K ﹤0.01% 560
2021
Q1
$15K Sell
1,101
-1,967
-64% -$32.1K 0.01% 516
2020
Q4
$57K Buy
+3,068
New +$50K 0.03% 338
2020
Q1
Sell
-163
Closed -$3K 998
2019
Q4
$3K Hold
163
﹤0.01% 721
2019
Q3
$3K Buy
163
+50
+44% +$980 ﹤0.01% 714
2019
Q2
$2K Buy
113
+80
+242% +$1.77K ﹤0.01% 780
2019
Q1
$1K Hold
33
﹤0.01% 919
2018
Q4
$1K Sell
33
-38
-54% -$1.23K ﹤0.01% 931
2018
Q3
$3K Buy
+71
New +$2.67K ﹤0.01% 738
2014
Q4
Sell
-899
Closed -$41K 447
2014
Q3
$41K Buy
899
+9
+1% +$437 0.02% 327
2014
Q2
$46K Buy
890
+165
+23% +$8.11K 0.02% 327
2014
Q1
$35K Buy
725
+619
+584% +$30.1K 0.01% 395
2013
Q4
$5K Sell
106
-4
-4% -$164 ﹤0.01% 567
2013
Q3
$4K Sell
110
-32
-23% -$1.13K ﹤0.01% 569
2013
Q2
$4K Buy
+142
New +$4.24K ﹤0.01% 572

Other funds holding VTRS

San Francisco Sentry Investment Group's VTRS Position: Q2 2021 in Review

San Francisco Sentry Investment Group reduced its Viatris (VTRS) stake by 62% in Q2 2021, selling an estimated $9.81K and leaving 423 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

San Francisco Sentry Investment Group first reported a position in VTRS in Q2 2013 and has held it in 15 quarters since. The position peaked at $57K in Q4 2020. 1,043 funds tracked by Wall St. Rank hold VTRS as of Q2 2021.

  • San Francisco Sentry Investment Group held 423 shares of Viatris worth $6K as of Q2 2021.
  • San Francisco Sentry Investment Group sold 678 Viatris shares in Q2 2021, an estimated $9.81K.
  • Viatris made up ﹤0.01% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #560 holding.
  • San Francisco Sentry Investment Group first reported a position in Viatris in Q2 2013 and has held it in 15 quarters since.
  • San Francisco Sentry Investment Group's Viatris position peaked at $57K in Q4 2020.
  • 1,043 funds tracked by Wall St. Rank held Viatris as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.